List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 20 studies with search of: "Bromfenac"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Determination of Optimum Duration of Treatment With Bromfenac (Xibrom) Eyedrops Following Cataract Surgery
Condition: Cataracts
Interventions: Drug: Bromfenac;   Drug: Moxifloxacin hydrochloride;   Drug: Prednisolone Acetate
2 Recruiting Evaluation of Comfort With Xibrom (Bromfenac Ophthalmic Solution)0.09% and Nevanac (Nepafenac Ophthalmic Suspension) 0.1% Following Selective Laser Trabeculoplasty (SLT)
Condition: Intraocular Pressure
Interventions: Drug: Xibrom;   Drug: Nevanac
3 Recruiting Comparing Optical Coherence Tomography (OCT) and Visual Acuity Outcomes in Subjects Undergoing Cataract Surgery, Who Receive Xibrom Ophthalmic Solution and Standard Presurgical Care vs. Xibrom Ophthalmic Solution Plus Prednisolone Acetate 1% and Standard Presurgical Care
Condition: Cataracts
Interventions: Drug: Xibrom, and Optive;   Drug: Xibrom and Pred Forte
4 Recruiting Combination Ranibizumab and Bromfenac for Neovascular Age-Related Macular Degeneration
Condition: Age-Related Macular Degeneration
Interventions: Drug: combination ranibizumab + bromfenac;   Drug: ranibizumab injection alone
5 Active, not recruiting Pilot Study of the Effect of Topical Bromfenac Ophthalmic Solution 0.09%in Patients With Acute Post-Operative Cystoid Macular Edema.
Condition: Cystoid Macular Edema
Interventions: Drug: Bromfenac (Xibrom);   Drug: Refresh Plus
6 Recruiting Safety Study of Bromfenac Ophthalmic Solution in Subjects With Diffuse Diabetic Macular Edema (DME) Refractory to Laser
Condition: Diabetic Macular Edema
Intervention: Drug: Bromfenac ophthalmic solution
7 Completed Bromfenac BID Plus Prednisolone Acetate BID Versus Bromfenac BID Plus Prednisolone QID for the Prevention of Cystoid Macular Edema and Retinal Thickening
Conditions: Cystoid Macular Edema,;   Retinal Thickening
Interventions: Drug: 2. Xibrom (Bromfenac);   Drug: 1. Pred Forte
8 Completed Bromfenac 0.09% vs Ketorolac 0.4% for Cyclosporine Induction Phase
Conditions: Dry Eye Disease;   Ocular Comfort
Interventions: Drug: bromfenac;   Drug: ketorolac
9 Active, not recruiting Efficacy and Safety of Topical Bromfenac Ophthalmic Solution vs. Placebo in Subjects With Allergic Conjunctivitis
Condition: Allergic Conjunctivitis
Intervention: Drug: bromfenac ophthalmic solution
10 Active, not recruiting Safety/Efficacy of Bromfenac Ophthalmic Solution for Ocular Inflammation and Pain Associated With Cataract Surgery
Conditions: Pain;   Inflammation
Intervention: Drug: bromfenac ophthalmic solution
11 Completed Safety and Efficacy Study of Topical Bromfenac Versus Placebo to Treat Ocular Inflammation After Cataract Surgery
Conditions: Postoperative Complications;   Cataract
Intervention: Drug: bromfenac sodium 0.09%
12 Completed Aqueous Concentrations and PGE2 Inhibition of Ketorolac 0.4% vs. Bromfenac 0.09% in Cataract Patients
Condition: Cataract
Intervention: Drug: ketorolac 0.4%, bromfenac 0.09%
13 Recruiting Randomized, Double Blind Trial of Bromfenac BID (0.09%) as an Adjunct to Argon Laser Therapy in the Treatment of Diabetic Macular Edema.
Condition: Diabetic Macular Edema
Interventions: Drug: Bromefenac;   Drug: Blink
14 Completed Treatment of Acute Pseudophakic Cystoid Macular Edema: Bromfenac 0.09% Versus Diclofenac Sodium 0.1% Versus Ketorolac Tromethamine 0.5%
Condition: Acute Pseudophakic Cystoid Macular Edema
Interventions: Drug: Bromfenac;   Drug: Ketorolac;   Drug: Diclofenac
15 Recruiting Efficacy and Safety of Bromfenac Ophthalmic Solution
Condition: Cataract Surgery
Intervention: Drug: bromfenac ophthalmic solution
16 Recruiting Efficacy and Safety of Bromfenac Ophthalmic Solution in Cataract Surgery
Condition: Cataract Extraction With Intraocular Lens Implantation
Interventions: Drug: bromfenac ophthalmic solution;   Drug: Placebo comparator
17 Recruiting Efficacy and Safety of Bromfenac Ophthalmic Solution in Cataract Surgery
Condition: Cataract Extraction
Interventions: Drug: bromfenac ophthalmic solution;   Drug: placebo
18 Recruiting Efficacy Study of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery
Conditions: Pain;   Inflammation
Interventions: Drug: Bromfenac Ophthalmic Solution;   Drug: Placebo Comparator
19 Completed Aqueous Concentrations and PGE2 Inhibition of Ketorolac 0.4% vs. Bromfenac 0.09% in Cataract Patients: Trough Drug Effects
Condition: Cataract
Intervention: Drug: Acular, Xibrom
20 Completed Comparison of Vitreous Levels of Acular LS 0.04%, Xibrom 0.09%, and Nevanac 0.1%
Condition: Vitrectomy
Interventions: Drug: Nepafenac;   Drug: Ketorolac LS, Bromfenac

Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services